Novel blood biomarkers of human urinary bladder cancer

Clinical Cancer Research

Volumn 12, Issue 11 I, 2006, Pages 3374-3380

  Osman, Iman ^a   Bajorin, Dean F ^b   Sun, Tung Tien ^a   Zhong, Hong ^a   Douglas, Diah ^a   Scattergood, Joseph ^b   Zheng, Run ^c   Han, Mark ^c   Marshall, K Wayne ^c   Liew, Choong Chin ^c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c GeneNews Limited   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; COMPLEMENTARY DNA; DNA BINDING PROTEIN; HELICASE; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN RELATED PROTEIN 7; PROTEOCHONDROITIN SULFATE; PROTEOCHONDROITIN SULFATE PROTEOGLYCAN 6; SOMATOMEDIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD ANALYSIS; BLOOD CELL; BLOOD SAMPLING; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MARKER; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; TESTIS CANCER; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, CD27; CARCINOMA, RENAL CELL; CATHEPSIN D; CELL CYCLE PROTEINS; CHROMOSOMAL PROTEINS, NON-HISTONE; CLUSTER ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOCHONDROITIN SULFATES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; VESICULAR TRANSPORT PROTEINS;

EID: 33745222255     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2081     Document Type: Article

References (30)

1. Liew CC, inventor; GeneNews, Inc., assignee. Method for the detection of gene transcripts in blood and uses thereof. United States patent US 20040014059. 2004 Jan 22 (priority date January 1999).
2. Ma J, Liew CC. Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. J Mol Cell Cardiol 2003;35: 993-8.
3. Bull TM, Coldren CD, Moore M, et al. Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am J Respir Crit Care Med 2004; 170:911-9.
4. Whistler T, Unger ER, Nisenbaum R, Vernon SD. Integration of gene expression, clinical, and epidemiologic data to characterize chronic fatigue syndrome. J Transl Med 2003;1:10.
5. Alcorta D, Preston G, Munger W, et al. Microarray studies of gene expression in circulating leukocytes in kidney diseases. Exp Nephrol 2002;10:139-49.
6. Lampe JW, Stepaniants SB, Mao M, et al. Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004;13:445-53.
7. Tsuang MT, Nossova N, Yager T et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005;133:1-5.
8. Grossfeld GD, Carroll PR. Evaluation of asymptomatic microscopic hematuria. Urol Clin North Am 1998; 25:661-76.
9. Herr HW. Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. World J Urol 1997;15:84-8.
10. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996;155:105-10.
11. Badalament RA, Hermansen DK, Kimmel M, et al. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer 1987;60: 1423-7.
12. Burchardt M, Burchardt T, Shabsigh A, De La Taille A, Benson MC, Sawczuk I. Current concepts in biomarker technology for bladder cancers. Clin Chem 2000;46:595-605.
13. Herr HW, Bajorin DF. Cancer of the bladder. In: Rosenberg S, editor. Cancer: principles and practice of oncology. Philadelphia: Lippincott, Williams, and Wilkins: 2001. p. 1396-18.
14. Pampel FC. Logistic regression: a primer. Sage quantitative applications in the social sciences series 132. Thousand Oaks: Sage Publications; 2000.
15. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95: 14863-8.
16. Yap Y, Zhang X, Ling MT, Wang X, Wong YC, Danchin A. Classification between normal and tumor tissues based on the pair-wise gene expression ratio. BMC Cancer 2004;4:72.
17. Hofmann HS, Hansen G, Burdach S, Bartling B, Silber RE, Simm A. Discrimination of human lung neoplasm from normal lung by two target genes. Am J Respir Crit Care Med 2004;170:516-9.
18. Mutaguchi K, Yasumoto H, Mita K, et al. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis inhuman prostate cancer. Cancer Res 2003;63:7717-23.
19. Sun HZ, Wu SF, Tu ZH. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity. Cell Res 2001;11: 107-15.
20. Miyake H, Hara I, Yamanaka K, Muramaki M, Eto H. Prognostic significance of insulin-like growth factor (IGF) binding protein-2 to IGF-binding protein-3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder. BJU Int 2005;95:987-91.
21. Bieche I, Lerebours F, Tozlu S, Espie M, Marty M, Lidereau R. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res 2004;10: 6789-95.
22. Mohr S, Bottin MC, Lannes B, et al. Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells. Biochimie 2004;86:13-9.
23. Ghiselli G, Siracusa LD, Iozzo RV. Complete cDNA cloning, genomic organization, chromosomal assignment, functional characterization of the promoter, and expression of the murine Bamacan gene. J Biol Chem 1999;274:17384-93.
24. Iacobuzio-Donahue C, Shuja S, Cai J, Peng P, Willett J, Murnane MJ. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function. Int J Oncol 2004;24:473-85.
25. Leto G, Tumminello FM, Crescimanno M, Flandina C, Gebbia N. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis 2004;21:91-106
26. Klaassens M, van Dooren M, Eussen HJ, et al. Congenital diaphragmatic hernia and chromosome 15q26: determination of a candidate region by use of fluorescent in situ hybridization and array-based comparative genomic hybridization. Am J Hum Genet 2005;76: 877-82.
27. Luce MJ, Burrows PD. The neuronal EGF-related genes NELL1 and NELL2 are expressed in hemopoietic cells and developmentally regulated in the B lineage. Gene 1999;231:121-6.
28. Abraham RS, Ballman KV, Dispenzieri A, et al. Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain am yloidosis. Blood 2005;105:794-803.
29. Osman I, Kang M, Lee A, et al. Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients. Int J Cancer 2004;111:934-9.
30. Twine NC, Stover JA, Marshall B, et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 2003;63:6069-75.